Through a partnership with Thailand’s Pharmaland (1982) Co., Ltd, Phaidros Healthcare is about to commercialize part of its General Medicine portfolio in South East Asia’s biggest market. “While Thailand has a complex regulatory landscape, its healthcare market is very dynamic and has been consistently growing during the last decade. We are glad to be able to access this market with our partner and be part of that growth story”, says Marc Wiethuechter, Managing Director of

Singapore’s Phaidros Healthcare has entered into an agreement with Serpentum Aeneum, a leading fertility and gynecology focused Korean healthcare company. The deal initially comprises Phaidros’s fertility and pregnancy range including brands such as Fertigel, Nausefem, Folitop, Fertina and Atrophyl among others. South Korea is the third largest healthcare market in the APAC region after China and Japan and the launch of Phaidros’s gynecological range in the country is expected to further drive value growth for

Singapore’s Phaidros Healthcare and Egypt’s Advocure Company have decided to enter into an exclusive agreement for the commercialization of Phaidros’s BonaVidea® product range. This move marks the first entrance of Phaidros into the North African territory. “We are delighted to be able to enter Egypt with a partner like Advocure, a well-established company which serves the healthcare needs of the Egyptian market since 18 years. We look forward to solidify our partnership further and constantly

Phaidros Healthcare and Examed Co., Ltd have entered into a commercial partnership for the distribution of Phaidros’ BonaVidea brand portfolio in Laos. The deal will comprise therapies in the area of fertility, intimate care and general medicine. “While Laos is the smallest country in the SEA region, we find entering early represents a unique opportunity to build our brands long term in a strongly growing economy. It also highlights our efforts to cover the South

Singapore, 31.01.2018 Phaidros Healthcare and German Quality Pharma have singed an exclusive partnership agreement for the commercialization of Phaidros’ healthcare product range in the Philippines. The deal comprises a number of German manufactured health supplements and medical devices of the BonaVidea® range and will mostly be targeted at the gynecologist community. “During the last years, the Philippines have exhibited strong economic growth and in particular the healthcare sector is very promising. We are glad to